AU5809100A - Stabilitats-, biokompatibilitats-optimiertes adjuvans (sba) zur erhohung der humoralen und zellularen immunantwort - Google Patents

Stabilitats-, biokompatibilitats-optimiertes adjuvans (sba) zur erhohung der humoralen und zellularen immunantwort

Info

Publication number
AU5809100A
AU5809100A AU58091/00A AU5809100A AU5809100A AU 5809100 A AU5809100 A AU 5809100A AU 58091/00 A AU58091/00 A AU 58091/00A AU 5809100 A AU5809100 A AU 5809100A AU 5809100 A AU5809100 A AU 5809100A
Authority
AU
Australia
Prior art keywords
zellularen
stabilitats
humoralen
biokompatibilitats
optimiertes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU58091/00A
Inventor
Nikolaus Grubhofer
Rainer Helmut Muller
Carsten Olbrich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PharmaSol GmbH
Original Assignee
PharmaSol GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DE19923256 priority Critical
Priority to DE19923256 priority
Application filed by PharmaSol GmbH filed Critical PharmaSol GmbH
Priority to PCT/EP2000/004644 priority patent/WO2000071077A2/en
Publication of AU5809100A publication Critical patent/AU5809100A/en
Application status is Abandoned legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
AU58091/00A 1999-05-20 2000-05-22 Stabilitats-, biokompatibilitats-optimiertes adjuvans (sba) zur erhohung der humoralen und zellularen immunantwort Abandoned AU5809100A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
DE19923256 1999-05-20
DE19923256 1999-05-20
PCT/EP2000/004644 WO2000071077A2 (en) 1999-05-20 2000-05-22 Adjuvant which is optimized with regard to stability and biocompatibility (sba) and which is provided for increasing the humoral and cellular immune response

Publications (1)

Publication Number Publication Date
AU5809100A true AU5809100A (en) 2000-12-12

Family

ID=7908697

Family Applications (2)

Application Number Title Priority Date Filing Date
AU52142/00A Abandoned AU5214200A (en) 1999-05-20 2000-05-19 Stability, biocompatibility optimized adjuvant (sba) for enhancing humoral and cellular immune response
AU58091/00A Abandoned AU5809100A (en) 1999-05-20 2000-05-22 Stabilitats-, biokompatibilitats-optimiertes adjuvans (sba) zur erhohung der humoralen und zellularen immunantwort

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU52142/00A Abandoned AU5214200A (en) 1999-05-20 2000-05-19 Stability, biocompatibility optimized adjuvant (sba) for enhancing humoral and cellular immune response

Country Status (10)

Country Link
EP (1) EP1183045A2 (en)
JP (1) JP2003500365A (en)
AU (2) AU5214200A (en)
BR (1) BR0010823A (en)
CA (1) CA2373239A1 (en)
DE (1) DE10024788A1 (en)
MX (1) MXPA01011660A (en)
TR (1) TR200103333T2 (en)
WO (2) WO2000071154A2 (en)
ZA (1) ZA200109147B (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10024788A1 (en) * 1999-05-20 2000-11-23 Gerbu Gmbh Substance for increasing an immune response during vaccinations or for increasing the production of antibodies, comprises solid lipid particles of a specific size and charge
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
EP1894591B1 (en) 2002-03-20 2013-06-26 MannKind Corporation Cartridge for an inhalation apparatus
JP2007509164A (en) * 2003-10-23 2007-04-12 カイロン コーポレイション Stabilizing composition
FR2873386B1 (en) 2004-07-22 2011-01-14 Agence Francaise De Securite Sanitaire Des Aliments Afssa vaccine composition against Rhodococcus equi
AU2005277208B2 (en) 2004-08-20 2011-11-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
DK2322180T3 (en) 2004-08-23 2015-06-15 Mannkind Corp Diketopiperazinsalte for drug delivery
KR20120060245A (en) 2005-09-14 2012-06-11 맨카인드 코포레이션 Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
JP5599975B2 (en) 2006-02-22 2014-10-01 マンカインド コーポレイション Method for improving the formulation properties of the fine particles containing diketopiperazine and an active agent
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
DK2570147T3 (en) 2008-06-13 2018-01-29 Mannkind Corp Dry powder inhaler and system for drug administration
RU2470681C2 (en) 2008-06-20 2012-12-27 Маннкайнд Корпорейшн Interactive system and method for real-time force profiling in inhalation
TWI614024B (en) 2008-08-11 2018-02-11 Mannkind Corp Use of ultrarapid acting insulin
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
DK2405963T3 (en) 2009-03-11 2013-12-16 Mannkind Corp An apparatus, system and method for measuring resistance in an inhaler
KR20190090092A (en) 2009-06-12 2019-07-31 맨카인드 코포레이션 Diketopiperazine microparticles with defined specific surface areas
EP2496295A1 (en) 2009-11-03 2012-09-12 MannKind Corporation An apparatus and method for simulating inhalation efforts
AU2011271097B2 (en) 2010-06-21 2014-11-27 Mannkind Corporation Dry powder drug delivery system and methods
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
AU2012328885B2 (en) 2011-10-24 2017-08-31 Mannkind Corporation Methods and compositions for treating pain
SG11201500218VA (en) 2012-07-12 2015-03-30 Mannkind Corp Dry powder drug delivery systems and methods
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
CA2918369A1 (en) 2013-07-18 2015-01-22 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
WO2017097783A1 (en) * 2015-12-08 2017-06-15 Glaxosmithkline Biologicals S.A. Novel adjuvant formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19745950A1 (en) * 1997-10-17 1999-04-22 Dds Drug Delivery Service Ges Drug carrier particle for site specific drug delivery, especially to CNS
EP1100464A1 (en) * 1998-07-31 2001-05-23 Korea Institute Of Science And Technology Lipid emulsion and solid lipid nanoparticle as a gene or drug carrier
DE10024788A1 (en) * 1999-05-20 2000-11-23 Gerbu Gmbh Substance for increasing an immune response during vaccinations or for increasing the production of antibodies, comprises solid lipid particles of a specific size and charge

Also Published As

Publication number Publication date
AU5214200A (en) 2000-12-12
JP2003500365A (en) 2003-01-07
WO2000071077A2 (en) 2000-11-30
TR200103333T2 (en) 2002-04-22
ZA200109147B (en) 2002-05-08
BR0010823A (en) 2002-03-05
WO2000071154A3 (en) 2001-06-28
CA2373239A1 (en) 2000-11-30
DE10024788A1 (en) 2000-11-23
WO2000071154A2 (en) 2000-11-30
EP1183045A2 (en) 2002-03-06
MXPA01011660A (en) 2004-04-05

Similar Documents

Publication Publication Date Title
AU745694C (en) Implant
AU4368100A (en) Proning bed
AU2711300A (en) Integrated filter
AU6420800A (en) Ventilated footwear
AU7867000A (en) Snapshot virtual-templating
AU4798000A (en) Triarylimidazoles
AU5430499A (en) Photobioreactor
AU1068401A (en) Inhaler
AU1465401A (en) Filter mask
AU5855800A (en) Laser-writable polymer composition
AU4151300A (en) Biomedical aid or implant
AU2070801A (en) Improved photoplethysmographic instrument
AU4198500A (en) Suture-passing forceps
AU7998900A (en) Automotive-ceiling-mounted monitor
AU5534600A (en) Inhalers
AU5259100A (en) Medicament
AU5413600A (en) Compounds
AU5414000A (en) Compounds
AU1529901A (en) Compounds
AU3489500A (en) Immediate post-extraction implant
AU2492000A (en) Implantable neuro-stimulator
AU5986200A (en) Compounds
AU1597100A (en) Flex sole
AU6479999A (en) Fracture treatment
AU5347799A (en) Keratome

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase